It uses genetic engineering to grow harmless copies of the virus S-protein to induce neutralising antibodies. The company said that recombinant ...
https://www.google.com/url?rct=j&sa=t&url=https://www.business-standard.com/article/current-affairs/china-approves-sinopharm-s-new-coronavirus-vaccine-for-clinical-trials-121041100291_1.html&ct=ga&cd=CAIyGjg0YzkwMzEwZTQwYzQxNjA6Y29tOmVuOlVT&usg=AFQjCNEr3SjNamxD7GO-7wTR5CMcTr6x7Q
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.